Rank | Gene Set | Z-score |
---|---|---|
1 | L-phenylalanine catabolic process (GO:0006559) | 6.11601024 |
2 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 6.11601024 |
3 | L-phenylalanine metabolic process (GO:0006558) | 5.88203214 |
4 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 5.88203214 |
5 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 5.72087786 |
6 | negative regulation of fibrinolysis (GO:0051918) | 5.62452812 |
7 | aromatic amino acid family catabolic process (GO:0009074) | 5.57251569 |
8 | regulation of fibrinolysis (GO:0051917) | 5.18512549 |
9 | protein carboxylation (GO:0018214) | 5.17929480 |
10 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.17929480 |
11 | high-density lipoprotein particle remodeling (GO:0034375) | 5.12943562 |
12 | tryptophan catabolic process (GO:0006569) | 5.12062231 |
13 | indole-containing compound catabolic process (GO:0042436) | 5.12062231 |
14 | indolalkylamine catabolic process (GO:0046218) | 5.12062231 |
15 | alpha-linolenic acid metabolic process (GO:0036109) | 5.05195048 |
16 | kynurenine metabolic process (GO:0070189) | 4.92691871 |
17 | bile acid biosynthetic process (GO:0006699) | 4.90542097 |
18 | regulation of protein activation cascade (GO:2000257) | 4.80879292 |
19 | complement activation, alternative pathway (GO:0006957) | 4.78906818 |
20 | very-low-density lipoprotein particle assembly (GO:0034379) | 4.78871322 |
21 | tryptophan metabolic process (GO:0006568) | 4.78513211 |
22 | urea cycle (GO:0000050) | 4.75867514 |
23 | urea metabolic process (GO:0019627) | 4.75867514 |
24 | reverse cholesterol transport (GO:0043691) | 4.62812834 |
25 | glyoxylate metabolic process (GO:0046487) | 4.59881999 |
26 | regulation of complement activation (GO:0030449) | 4.53082617 |
27 | plasma lipoprotein particle assembly (GO:0034377) | 4.50426479 |
28 | regulation of cholesterol esterification (GO:0010872) | 4.49909325 |
29 | cysteine metabolic process (GO:0006534) | 4.49886228 |
30 | sulfur amino acid catabolic process (GO:0000098) | 4.49368512 |
31 | phospholipid efflux (GO:0033700) | 4.43020596 |
32 | triglyceride homeostasis (GO:0070328) | 4.40608459 |
33 | acylglycerol homeostasis (GO:0055090) | 4.40608459 |
34 | regulation of cholesterol homeostasis (GO:2000188) | 4.39466947 |
35 | regulation of triglyceride catabolic process (GO:0010896) | 4.38142326 |
36 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 4.32551192 |
37 | nitrogen cycle metabolic process (GO:0071941) | 4.31927498 |
38 | plasma lipoprotein particle clearance (GO:0034381) | 4.30533756 |
39 | negative regulation of cholesterol transport (GO:0032375) | 4.28409109 |
40 | negative regulation of sterol transport (GO:0032372) | 4.28409109 |
41 | protein-lipid complex remodeling (GO:0034368) | 4.25887178 |
42 | macromolecular complex remodeling (GO:0034367) | 4.25887178 |
43 | plasma lipoprotein particle remodeling (GO:0034369) | 4.25887178 |
44 | homocysteine metabolic process (GO:0050667) | 4.25299411 |
45 | bile acid metabolic process (GO:0008206) | 4.16974697 |
46 | protein-lipid complex assembly (GO:0065005) | 4.15101489 |
47 | serine family amino acid catabolic process (GO:0009071) | 4.05145210 |
48 | adhesion of symbiont to host cell (GO:0044650) | 4.03982364 |
49 | virion attachment to host cell (GO:0019062) | 4.03982364 |
50 | fibrinolysis (GO:0042730) | 4.03201101 |
51 | aromatic amino acid family metabolic process (GO:0009072) | 4.02926173 |
52 | skin morphogenesis (GO:0043589) | 4.01705902 |
53 | cholesterol efflux (GO:0033344) | 3.90711445 |
54 | cellular glucuronidation (GO:0052695) | 3.87145646 |
55 | positive regulation of fatty acid beta-oxidation (GO:0032000) | 3.85636698 |
56 | cell adhesion mediated by integrin (GO:0033627) | 3.80769445 |
57 | amino-acid betaine metabolic process (GO:0006577) | 3.80568943 |
58 | endodermal cell differentiation (GO:0035987) | 3.79780551 |
59 | tyrosine metabolic process (GO:0006570) | 3.79279723 |
60 | barbed-end actin filament capping (GO:0051016) | 3.76068242 |
61 | bile acid and bile salt transport (GO:0015721) | 3.74775068 |
62 | positive regulation of extracellular matrix organization (GO:1903055) | 3.74652989 |
63 | adhesion of symbiont to host (GO:0044406) | 3.71942618 |
64 | positive regulation of lipid catabolic process (GO:0050996) | 3.69930298 |
65 | indolalkylamine metabolic process (GO:0006586) | 3.68216915 |
66 | plasma lipoprotein particle organization (GO:0071827) | 3.67945753 |
67 | regulation of plasminogen activation (GO:0010755) | 3.67669869 |
68 | lysine metabolic process (GO:0006553) | 3.67467895 |
69 | lysine catabolic process (GO:0006554) | 3.67467895 |
70 | alpha-amino acid catabolic process (GO:1901606) | 3.66918921 |
71 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.66606011 |
72 | phospholipid homeostasis (GO:0055091) | 3.60393428 |
73 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.60063699 |
74 | protein-lipid complex subunit organization (GO:0071825) | 3.52755805 |
75 | complement activation, classical pathway (GO:0006958) | 3.52017306 |
76 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.51580283 |
77 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.51580283 |
78 | amine catabolic process (GO:0009310) | 3.50251441 |
79 | cellular biogenic amine catabolic process (GO:0042402) | 3.50251441 |
80 | complement activation (GO:0006956) | 3.50187964 |
81 | regulation of bile acid biosynthetic process (GO:0070857) | 3.45858268 |
82 | coenzyme catabolic process (GO:0009109) | 3.45653891 |
83 | ethanol oxidation (GO:0006069) | 3.45381142 |
84 | protein heterotrimerization (GO:0070208) | 3.45272702 |
85 | negative regulation of lipase activity (GO:0060192) | 3.45179858 |
86 | collagen fibril organization (GO:0030199) | 3.45155333 |
87 | cholesterol homeostasis (GO:0042632) | 3.43159769 |
88 | low-density lipoprotein particle remodeling (GO:0034374) | 3.42798333 |
89 | cellular ketone body metabolic process (GO:0046950) | 3.39149904 |
90 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 3.38542801 |
91 | glutamate metabolic process (GO:0006536) | 3.38536041 |
92 | dicarboxylic acid biosynthetic process (GO:0043650) | 3.38299262 |
93 | protein activation cascade (GO:0072376) | 3.38062965 |
94 | drug catabolic process (GO:0042737) | 3.37780879 |
95 | imidazole-containing compound metabolic process (GO:0052803) | 3.37758950 |
96 | glucuronate metabolic process (GO:0019585) | 3.37693278 |
97 | uronic acid metabolic process (GO:0006063) | 3.37693278 |
98 | sterol homeostasis (GO:0055092) | 3.37112966 |
99 | benzene-containing compound metabolic process (GO:0042537) | 3.36524354 |
100 | lipoprotein metabolic process (GO:0042157) | 3.34450944 |
101 | cellular amino acid catabolic process (GO:0009063) | 3.32614177 |
102 | cellular modified amino acid catabolic process (GO:0042219) | 3.32130773 |
103 | acute-phase response (GO:0006953) | 3.30855386 |
104 | basement membrane organization (GO:0071711) | 3.30401556 |
105 | glycine metabolic process (GO:0006544) | 3.25095330 |
106 | arginine metabolic process (GO:0006525) | 3.25070905 |
107 | low-density lipoprotein particle clearance (GO:0034383) | 3.24853600 |
108 | positive regulation of fatty acid oxidation (GO:0046321) | 3.21689617 |
109 | regulation of fatty acid beta-oxidation (GO:0031998) | 3.19056733 |
110 | epoxygenase P450 pathway (GO:0019373) | 3.18753950 |
111 | negative regulation of protein activation cascade (GO:2000258) | 3.18632591 |
112 | apoptotic cell clearance (GO:0043277) | 3.17885832 |
113 | serine family amino acid metabolic process (GO:0009069) | 3.16675095 |
114 | positive regulation of endothelial cell apoptotic process (GO:2000353) | 3.16489577 |
115 | extracellular fibril organization (GO:0043206) | 3.15611826 |
116 | blood coagulation, intrinsic pathway (GO:0007597) | 3.15248548 |
117 | protein localization to endosome (GO:0036010) | 3.14601457 |
118 | stress fiber assembly (GO:0043149) | 3.11765830 |
119 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 3.10215893 |
120 | response to nitrosative stress (GO:0051409) | 3.09666954 |
121 | flavonoid metabolic process (GO:0009812) | 3.09629137 |
122 | cell migration involved in heart development (GO:0060973) | 3.07930621 |
123 | chondrocyte proliferation (GO:0035988) | 3.05944085 |
124 | retina vasculature morphogenesis in camera-type eye (GO:0061299) | 3.02111923 |
125 | fibril organization (GO:0097435) | 2.99797753 |
126 | substrate-dependent cell migration (GO:0006929) | 2.96298430 |
127 | wound healing, spreading of epidermal cells (GO:0035313) | 2.88804410 |
128 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.85779880 |
129 | negative regulation of fatty acid transport (GO:2000192) | 2.85507183 |
130 | collagen metabolic process (GO:0032963) | 2.83802866 |
131 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.81344402 |
132 | hyaluronan catabolic process (GO:0030214) | 2.80757790 |
133 | keratan sulfate catabolic process (GO:0042340) | 2.77361647 |
134 | regulation of mononuclear cell migration (GO:0071675) | 2.76474430 |
135 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.73188922 |
136 | negative regulation of hemostasis (GO:1900047) | 2.72480175 |
137 | negative regulation of blood coagulation (GO:0030195) | 2.72480175 |
138 | negative regulation of coagulation (GO:0050819) | 2.72143099 |
139 | hemidesmosome assembly (GO:0031581) | 2.71754176 |
140 | collagen catabolic process (GO:0030574) | 2.69591971 |
141 | regulation of early endosome to late endosome transport (GO:2000641) | 2.69162383 |
142 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.67455177 |
143 | type B pancreatic cell proliferation (GO:0044342) | 2.65289036 |
144 | extracellular matrix disassembly (GO:0022617) | 2.64889221 |
145 | positive regulation of p38MAPK cascade (GO:1900745) | 2.64650843 |
146 | cell-substrate junction assembly (GO:0007044) | 2.62910192 |
147 | regulation of extracellular matrix disassembly (GO:0010715) | 2.62909342 |
148 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.61373012 |
149 | regulation of integrin-mediated signaling pathway (GO:2001044) | 2.60390235 |
150 | venous blood vessel morphogenesis (GO:0048845) | 2.58627771 |
151 | protein retention in ER lumen (GO:0006621) | 2.58574281 |
152 | multicellular organismal metabolic process (GO:0044236) | 2.56674880 |
153 | negative regulation of wound healing (GO:0061045) | 2.55461404 |
154 | regulation of extracellular matrix organization (GO:1903053) | 2.54331783 |
155 | positive regulation of hemostasis (GO:1900048) | 2.54193950 |
156 | positive regulation of blood coagulation (GO:0030194) | 2.54193950 |
157 | regulation of apoptotic cell clearance (GO:2000425) | 2.54044135 |
158 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.53532981 |
159 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.52480608 |
160 | pinocytosis (GO:0006907) | 2.51899528 |
161 | multicellular organismal catabolic process (GO:0044243) | 2.51783026 |
162 | positive regulation of astrocyte differentiation (GO:0048711) | 2.48734942 |
163 | epithelial cell-cell adhesion (GO:0090136) | 2.48137771 |
164 | extracellular matrix assembly (GO:0085029) | 2.47124343 |
165 | endothelial cell morphogenesis (GO:0001886) | 2.45200003 |
166 | positive regulation of coagulation (GO:0050820) | 2.44397821 |
167 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.43232875 |
168 | glial cell migration (GO:0008347) | 2.43005362 |
169 | positive regulation of receptor recycling (GO:0001921) | 2.41185931 |
170 | positive regulation of osteoblast proliferation (GO:0033690) | 2.38975331 |
171 | dichotomous subdivision of an epithelial terminal unit (GO:0060600) | 2.37964719 |
172 | regulation of macrophage chemotaxis (GO:0010758) | 2.35123725 |
173 | regulation of endothelial cell apoptotic process (GO:2000351) | 2.34741964 |
174 | cellular response to vascular endothelial growth factor stimulus (GO:0035924) | 2.34552615 |
175 | extracellular matrix organization (GO:0030198) | 2.32649523 |
176 | extracellular structure organization (GO:0043062) | 2.31581644 |
177 | negative regulation of lipid transport (GO:0032369) | 2.31289333 |
178 | wound healing, spreading of cells (GO:0044319) | 2.30887310 |
179 | platelet degranulation (GO:0002576) | 2.30859073 |
180 | endocytic recycling (GO:0032456) | 2.29886029 |
181 | peptidyl-proline hydroxylation (GO:0019511) | 2.29682292 |
182 | kidney mesenchyme development (GO:0072074) | 2.27927483 |
183 | glomerular basement membrane development (GO:0032836) | 2.27665144 |
184 | positive regulation of wound healing (GO:0090303) | 2.26986353 |
185 | cellular response to vitamin (GO:0071295) | 2.26259779 |
186 | response to magnesium ion (GO:0032026) | 2.25418840 |
187 | cell proliferation involved in metanephros development (GO:0072203) | 2.24702661 |
Rank | Gene Set | Z-score |
---|---|---|
1 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 9.22809219 |
2 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 6.52537174 |
3 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 5.65338748 |
4 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 5.46809120 |
5 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 5.00360979 |
6 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 4.45760330 |
7 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 4.15836568 |
8 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 3.58866557 |
9 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 3.55143856 |
10 | CLOCK_20551151_ChIP-Seq_293T_Human | 2.95753083 |
11 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 2.42684710 |
12 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.36729349 |
13 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.19688266 |
14 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.16873570 |
15 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 2.16807383 |
16 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.02944407 |
17 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.89479665 |
18 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.84142661 |
19 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.82290644 |
20 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 1.77111085 |
21 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.72749586 |
22 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.67363148 |
23 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.66786466 |
24 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.62181491 |
25 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.51891030 |
26 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.49752471 |
27 | GATA1_22025678_ChIP-Seq_K562_Human | 1.48773626 |
28 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 1.48435816 |
29 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.46739022 |
30 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.46491255 |
31 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.42352551 |
32 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.40798883 |
33 | * BRD4_25478319_ChIP-Seq_HGPS_Human | 1.39339583 |
34 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.39051153 |
35 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.36941996 |
36 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.35803811 |
37 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.33158319 |
38 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.32988634 |
39 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.30382631 |
40 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.29817676 |
41 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.29676126 |
42 | KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.29466007 |
43 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.29047281 |
44 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.29043705 |
45 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.27685174 |
46 | KDM2B_26808549_Chip-Seq_K562_Human | 1.26391273 |
47 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.24317123 |
48 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.23842237 |
49 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.22983056 |
50 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.21762521 |
51 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.21215197 |
52 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.15348843 |
53 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.13701112 |
54 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.13473585 |
55 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 1.10525853 |
56 | HNF4A_19822575_ChIP-Seq_HepG2_Human | 1.09054113 |
57 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.08457407 |
58 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.07713517 |
59 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.06115938 |
60 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.04402248 |
61 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.03303422 |
62 | CJUN_26792858_Chip-Seq_BT549_Human | 1.01891750 |
63 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.01802524 |
64 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.01601076 |
65 | GATA4_25053715_ChIP-Seq_YYC3_Human | 1.01507761 |
66 | SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.00586809 |
67 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.00229978 |
68 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.00127418 |
69 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.99916216 |
70 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 0.98580584 |
71 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.97764439 |
72 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.97764439 |
73 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.97254951 |
74 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.96131883 |
75 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.96131883 |
76 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.95628172 |
77 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.94915367 |
78 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.94426492 |
79 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 0.91974561 |
80 | TP53_23651856_ChIP-Seq_MEFs_Mouse | 0.91735699 |
81 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.91656859 |
82 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.91252887 |
83 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.90928678 |
84 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.90334063 |
85 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.90296783 |
86 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.88631679 |
87 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.88156567 |
88 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.88079577 |
89 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.88001675 |
90 | GATA1_19941826_ChIP-Seq_K562_Human | 0.87912619 |
91 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 0.87187450 |
92 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86764862 |
93 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.86543272 |
94 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 0.85701903 |
95 | AR_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.85623786 |
96 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.84971029 |
97 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.84549577 |
98 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.83801180 |
99 | RUNX_20019798_ChIP-Seq_JUKART_Human | 0.83788632 |
100 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.83747979 |
101 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.83747979 |
102 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 0.83197308 |
103 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.82772205 |
104 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.82486509 |
105 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.82186543 |
106 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 0.82016434 |
107 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.81721674 |
108 | LXR_22292898_ChIP-Seq_THP-1_Human | 0.79456324 |
109 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.79054318 |
110 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.78210841 |
111 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.78028911 |
112 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.76587939 |
113 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.75914520 |
114 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.75914520 |
115 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.74866057 |
116 | RXRA_24833708_ChIP-Seq_LIVER_Mouse | 0.73751275 |
117 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.72817763 |
118 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.69409143 |
119 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 0.67345659 |
120 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 0.65939159 |
121 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.65553812 |
122 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.65403942 |
123 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.65267375 |
124 | VDR_24787735_ChIP-Seq_THP-1_Human | 0.65218126 |
125 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.63613913 |
126 | PPARG_20887899_ChIP-Seq_3T3-L1_Mouse | 0.63448067 |
127 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.62457491 |
128 | ATF3_27146783_Chip-Seq_COLON_Human | 0.59548068 |
129 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 0.58069723 |
130 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.57951592 |
131 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.57726215 |
132 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.56200011 |
133 | CEBPB_22108803_ChIP-Seq_LS180_Human | 0.56140385 |
134 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.55039672 |
135 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.53615759 |
136 | HTT_18923047_ChIP-ChIP_STHdh_Human | 0.53445063 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0002139_abnormal_hepatobiliary_system | 7.38466147 |
2 | MP0005360_urolithiasis | 6.43185267 |
3 | MP0005085_abnormal_gallbladder_physiolo | 5.17757673 |
4 | MP0005365_abnormal_bile_salt | 5.12542074 |
5 | MP0008875_abnormal_xenobiotic_pharmacok | 4.36636845 |
6 | MP0003252_abnormal_bile_duct | 3.53705492 |
7 | MP0010329_abnormal_lipoprotein_level | 3.31915806 |
8 | MP0009840_abnormal_foam_cell | 3.19418954 |
9 | MP0003806_abnormal_nucleotide_metabolis | 3.00501329 |
10 | MP0005257_abnormal_intraocular_pressure | 2.99753710 |
11 | MP0002138_abnormal_hepatobiliary_system | 2.88729055 |
12 | MP0005503_abnormal_tendon_morphology | 2.79402359 |
13 | MP0005058_abnormal_lysosome_morphology | 2.58556713 |
14 | MP0005083_abnormal_biliary_tract | 2.41690190 |
15 | MP0003191_abnormal_cellular_cholesterol | 2.36105663 |
16 | MP0006054_spinal_hemorrhage | 2.26452720 |
17 | MP0003950_abnormal_plasma_membrane | 2.26392723 |
18 | MP0010368_abnormal_lymphatic_system | 2.24595106 |
19 | MP0005332_abnormal_amino_acid | 2.12007770 |
20 | MP0001666_abnormal_nutrient_absorption | 2.11320320 |
21 | MP0000609_abnormal_liver_physiology | 2.10299182 |
22 | MP0003705_abnormal_hypodermis_morpholog | 2.09478872 |
23 | MP0004019_abnormal_vitamin_homeostasis | 1.99261477 |
24 | MP0001542_abnormal_bone_strength | 1.88363917 |
25 | MP0005623_abnormal_meninges_morphology | 1.86624696 |
26 | MP0002118_abnormal_lipid_homeostasis | 1.83680568 |
27 | MP0003195_calcinosis | 1.56179594 |
28 | MP0005319_abnormal_enzyme/_coenzyme | 1.47244136 |
29 | MP0002254_reproductive_system_inflammat | 1.46054789 |
30 | MP0003941_abnormal_skin_development | 1.43460243 |
31 | MP0005508_abnormal_skeleton_morphology | 1.42969743 |
32 | MP0002877_abnormal_melanocyte_morpholog | 1.40557382 |
33 | MP0002896_abnormal_bone_mineralization | 1.39483462 |
34 | MP0003011_delayed_dark_adaptation | 1.38180481 |
35 | MP0003868_abnormal_feces_composition | 1.31417824 |
36 | MP0003724_increased_susceptibility_to | 1.29417467 |
37 | MP0008438_abnormal_cutaneous_collagen | 1.27672054 |
38 | MP0002998_abnormal_bone_remodeling | 1.25467240 |
39 | MP0009780_abnormal_chondrocyte_physiolo | 1.23760463 |
40 | MP0005584_abnormal_enzyme/coenzyme_acti | 1.22339930 |
41 | MP0003448_altered_tumor_morphology | 1.21974690 |
42 | MP0004858_abnormal_nervous_system | 1.19331435 |
43 | MP0000685_abnormal_immune_system | 1.17977572 |
44 | MP0009764_decreased_sensitivity_to | 1.17495624 |
45 | MP0000858_altered_metastatic_potential | 1.13457598 |
46 | MP0003828_pulmonary_edema | 1.11724111 |
47 | MP0000013_abnormal_adipose_tissue | 1.11629498 |
48 | MP0000751_myopathy | 1.11368107 |
49 | MP0001849_ear_inflammation | 1.11167598 |
50 | MP0009643_abnormal_urine_homeostasis | 1.11079427 |
51 | MP0000003_abnormal_adipose_tissue | 1.07526329 |
52 | MP0005390_skeleton_phenotype | 1.06257613 |
53 | MP0000598_abnormal_liver_morphology | 1.04701653 |
54 | MP0001790_abnormal_immune_system | 1.04315654 |
55 | MP0005387_immune_system_phenotype | 1.04315654 |
56 | MP0001879_abnormal_lymphatic_vessel | 1.03143119 |
57 | MP0003300_gastrointestinal_ulcer | 1.01579023 |
58 | MP0009763_increased_sensitivity_to | 1.01104704 |
59 | MP0003303_peritoneal_inflammation | 1.00282804 |
60 | MP0006082_CNS_inflammation | 1.00270825 |
61 | MP0005275_abnormal_skin_tensile | 0.98465343 |
62 | MP0001915_intracranial_hemorrhage | 0.98333645 |
63 | MP0004782_abnormal_surfactant_physiolog | 0.97967568 |
64 | MP0000604_amyloidosis | 0.96852474 |
65 | MP0005375_adipose_tissue_phenotype | 0.95013929 |
66 | MP0003566_abnormal_cell_adhesion | 0.94355527 |
67 | MP0010352_gastrointestinal_tract_polyps | 0.93949344 |
68 | MP0008469_abnormal_protein_level | 0.93814041 |
69 | MP0009697_abnormal_copulation | 0.92721811 |
70 | MP0010030_abnormal_orbit_morphology | 0.92280166 |
71 | MP0003329_amyloid_beta_deposits | 0.91517220 |
72 | MP0000249_abnormal_blood_vessel | 0.90946595 |
73 | MP0009384_cardiac_valve_regurgitation | 0.90375339 |
74 | MP0001764_abnormal_homeostasis | 0.90342948 |
75 | MP0002108_abnormal_muscle_morphology | 0.89649042 |
76 | MP0005023_abnormal_wound_healing | 0.89202976 |
77 | MP0005197_abnormal_uvea_morphology | 0.88316468 |
78 | MP0002060_abnormal_skin_morphology | 0.87660098 |
79 | MP0003172_abnormal_lysosome_physiology | 0.85026395 |
80 | MP0006138_congestive_heart_failure | 0.83729361 |
81 | MP0009053_abnormal_anal_canal | 0.82972980 |
82 | MP0005647_abnormal_sex_gland | 0.82866602 |
83 | MP0000733_abnormal_muscle_development | 0.82714438 |
84 | MP0005451_abnormal_body_composition | 0.81323530 |
85 | MP0003186_abnormal_redox_activity | 0.80480304 |
86 | MP0004947_skin_inflammation | 0.80202475 |
87 | MP0003453_abnormal_keratinocyte_physiol | 0.79486756 |
88 | MP0001958_emphysema | 0.79342048 |
89 | MP0003638_abnormal_response/metabolism_ | 0.79275546 |
90 | MP0002168_other_aberrant_phenotype | 0.78096836 |
91 | MP0001614_abnormal_blood_vessel | 0.77627112 |
92 | MP0002136_abnormal_kidney_physiology | 0.77298904 |
93 | MP0001881_abnormal_mammary_gland | 0.76652563 |
94 | MP0003436_decreased_susceptibility_to | 0.75417327 |
95 | MP0004272_abnormal_basement_membrane | 0.75301432 |
96 | MP0001243_abnormal_dermal_layer | 0.74674600 |
97 | MP0005164_abnormal_response_to | 0.74328532 |
98 | MP0001853_heart_inflammation | 0.73369190 |
99 | MP0000749_muscle_degeneration | 0.72548548 |
100 | MP0004510_myositis | 0.71999698 |
101 | MP0009642_abnormal_blood_homeostasis | 0.71903348 |
102 | MP0005409_darkened_coat_color | 0.71743432 |
103 | MP0009765_abnormal_xenobiotic_induced | 0.70214962 |
104 | MP0009250_abnormal_appendicular_skeleto | 0.69900175 |
105 | MP0000163_abnormal_cartilage_morphology | 0.69898976 |
106 | MP0005167_abnormal_blood-brain_barrier | 0.69854389 |
107 | MP0000762_abnormal_tongue_morphology | 0.69677916 |
108 | MP0002295_abnormal_pulmonary_circulatio | 0.69146174 |
109 | MP0001299_abnormal_eye_distance/ | 0.68026846 |
110 | MP0005666_abnormal_adipose_tissue | 0.67568927 |
111 | MP0005464_abnormal_platelet_physiology | 0.67211622 |
112 | MP0003795_abnormal_bone_structure | 0.67150997 |
113 | MP0004883_abnormal_blood_vessel | 0.66989148 |
114 | MP0002933_joint_inflammation | 0.66874101 |
115 | MP0002928_abnormal_bile_duct | 0.66134299 |
116 | MP0005334_abnormal_fat_pad | 0.66064203 |
117 | MP0008260_abnormal_autophagy | 0.65455488 |
118 | MP0001800_abnormal_humoral_immune | 0.65108122 |
119 | MP0002148_abnormal_hypersensitivity_rea | 0.64831420 |
120 | MP0002113_abnormal_skeleton_development | 0.64774766 |
121 | MP0001845_abnormal_inflammatory_respons | 0.64374560 |
122 | MP0002971_abnormal_brown_adipose | 0.64356141 |
123 | MP0005193_abnormal_anterior_eye | 0.64242251 |
124 | MP0005076_abnormal_cell_differentiation | 0.64213615 |
125 | MP0003634_abnormal_glial_cell | 0.64022119 |
126 | MP0002089_abnormal_postnatal_growth/wei | 0.63408189 |
127 | MP0002332_abnormal_exercise_endurance | 0.63039840 |
128 | MP0000343_altered_response_to | 0.61688164 |
129 | MP0003091_abnormal_cell_migration | 0.60311089 |
130 | MP0001533_abnormal_skeleton_physiology | 0.59769329 |
131 | MP0005408_hypopigmentation | 0.57830335 |
132 | MP0003279_aneurysm | 0.57763349 |
133 | MP0003075_altered_response_to | 0.56481135 |
134 | MP0005376_homeostasis/metabolism_phenot | 0.56237400 |
135 | MP0000767_abnormal_smooth_muscle | 0.55194752 |
136 | MP0002128_abnormal_blood_circulation | 0.54948733 |
137 | MP0009785_altered_susceptibility_to | 0.54823514 |
138 | MP0010155_abnormal_intestine_physiology | 0.53959293 |
139 | MP0005084_abnormal_gallbladder_morpholo | 0.53646132 |
140 | MP0010234_abnormal_vibrissa_follicle | 0.53036171 |
141 | MP0004130_abnormal_muscle_cell | 0.52983888 |
142 | MP0005670_abnormal_white_adipose | 0.51966754 |
143 | MP0000427_abnormal_hair_cycle | 0.51746674 |
144 | MP0003656_abnormal_erythrocyte_physiolo | 0.51723497 |
145 | MP0005595_abnormal_vascular_smooth | 0.51406262 |
146 | MP0005166_decreased_susceptibility_to | 0.51395111 |
147 | MP0002796_impaired_skin_barrier | 0.51234944 |
148 | MP0005165_increased_susceptibility_to | 0.50871458 |
149 | MP0003045_fibrosis | 0.50681734 |
150 | MP0003690_abnormal_glial_cell | 0.50627791 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Deep venous thrombosis (HP:0002625) | 7.33019134 |
2 | Premature rupture of membranes (HP:0001788) | 6.36618977 |
3 | Intrahepatic cholestasis (HP:0001406) | 6.31962096 |
4 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 5.94101862 |
5 | Xanthomatosis (HP:0000991) | 5.85957279 |
6 | Hypobetalipoproteinemia (HP:0003563) | 5.83646074 |
7 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 5.80623117 |
8 | Prolonged partial thromboplastin time (HP:0003645) | 5.31503018 |
9 | Complement deficiency (HP:0004431) | 5.06849155 |
10 | Hyperlipoproteinemia (HP:0010980) | 4.78344444 |
11 | Hypolipoproteinemia (HP:0010981) | 4.54868200 |
12 | Joint hemorrhage (HP:0005261) | 4.32476153 |
13 | Abnormality of the common coagulation pathway (HP:0010990) | 4.14582242 |
14 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 4.12519378 |
15 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 4.10207731 |
16 | Hypoalphalipoproteinemia (HP:0003233) | 4.08766604 |
17 | Aortic dissection (HP:0002647) | 3.98425435 |
18 | Epidermoid cyst (HP:0200040) | 3.95177506 |
19 | Hyperammonemia (HP:0001987) | 3.87680848 |
20 | Vascular tortuosity (HP:0004948) | 3.84844233 |
21 | Abnormality of complement system (HP:0005339) | 3.78309765 |
22 | Aortic aneurysm (HP:0004942) | 3.71364255 |
23 | Vertebral compression fractures (HP:0002953) | 3.69918442 |
24 | Myocardial infarction (HP:0001658) | 3.62880232 |
25 | Atrophic scars (HP:0001075) | 3.57552351 |
26 | Fat malabsorption (HP:0002630) | 3.54711460 |
27 | Abnormality of glycolipid metabolism (HP:0010969) | 3.47127002 |
28 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.47127002 |
29 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.47127002 |
30 | Arterial tortuosity (HP:0005116) | 3.44243626 |
31 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 3.41962358 |
32 | Hyperglycinuria (HP:0003108) | 3.30767428 |
33 | Ketosis (HP:0001946) | 3.28602056 |
34 | Hypercholesterolemia (HP:0003124) | 3.26110970 |
35 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 3.24295900 |
36 | Abnormality of the intrinsic pathway (HP:0010989) | 3.24135924 |
37 | Abnormality of methionine metabolism (HP:0010901) | 3.23403152 |
38 | Cervical subluxation (HP:0003308) | 3.23235459 |
39 | Hyperglycinemia (HP:0002154) | 3.21167575 |
40 | Ankle contracture (HP:0006466) | 3.20195270 |
41 | Abnormality of serine family amino acid metabolism (HP:0010894) | 3.17497617 |
42 | Abnormality of glycine metabolism (HP:0010895) | 3.17497617 |
43 | Soft skin (HP:0000977) | 3.16718327 |
44 | Hypoglycemic coma (HP:0001325) | 3.14092063 |
45 | Cerebral aneurysm (HP:0004944) | 3.01576336 |
46 | Neonatal short-limb short stature (HP:0008921) | 3.00882304 |
47 | Bladder diverticulum (HP:0000015) | 2.99981568 |
48 | Esophageal varix (HP:0002040) | 2.99566277 |
49 | Fragile skin (HP:0001030) | 2.97349744 |
50 | Spinal rigidity (HP:0003306) | 2.96428937 |
51 | Wormian bones (HP:0002645) | 2.91343988 |
52 | Hepatocellular carcinoma (HP:0001402) | 2.91204413 |
53 | Mitral stenosis (HP:0001718) | 2.85820851 |
54 | Spontaneous abortion (HP:0005268) | 2.81697815 |
55 | Vascular calcification (HP:0004934) | 2.81210762 |
56 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.79721606 |
57 | Blue sclerae (HP:0000592) | 2.79537442 |
58 | Spondylolisthesis (HP:0003302) | 2.77548587 |
59 | Conjugated hyperbilirubinemia (HP:0002908) | 2.75849258 |
60 | Dysostosis multiplex (HP:0000943) | 2.75834098 |
61 | Follicular hyperkeratosis (HP:0007502) | 2.72367274 |
62 | Cardiovascular calcification (HP:0011915) | 2.69303365 |
63 | Systemic lupus erythematosus (HP:0002725) | 2.68251491 |
64 | Dilatation of the ascending aorta (HP:0005111) | 2.66875085 |
65 | Axonal loss (HP:0003447) | 2.65956941 |
66 | Shallow orbits (HP:0000586) | 2.65195500 |
67 | Polycythemia (HP:0001901) | 2.64684058 |
68 | Abnormality of dentin (HP:0010299) | 2.64442233 |
69 | Skin nodule (HP:0200036) | 2.63363657 |
70 | Abnormality of proline metabolism (HP:0010907) | 2.60929621 |
71 | Hydroxyprolinuria (HP:0003080) | 2.60929621 |
72 | Thrombophlebitis (HP:0004418) | 2.60520738 |
73 | Genu recurvatum (HP:0002816) | 2.57325989 |
74 | Abnormality of fatty-acid metabolism (HP:0004359) | 2.55841794 |
75 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.54591440 |
76 | Mucopolysacchariduria (HP:0008155) | 2.54591440 |
77 | Increased density of long bones (HP:0006392) | 2.54196343 |
78 | Broad metatarsal (HP:0001783) | 2.52508057 |
79 | Steatorrhea (HP:0002570) | 2.51756641 |
80 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.50797057 |
81 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.50797057 |
82 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.50797057 |
83 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 2.50723446 |
84 | Pulmonary embolism (HP:0002204) | 2.50466870 |
85 | Achilles tendon contracture (HP:0001771) | 2.49549003 |
86 | Amyloidosis (HP:0011034) | 2.44156537 |
87 | Type 1 muscle fiber predominance (HP:0003803) | 2.43578601 |
88 | Hyperbilirubinemia (HP:0002904) | 2.43015486 |
89 | Glomerulonephritis (HP:0000099) | 2.41114856 |
90 | Abnormality of nucleobase metabolism (HP:0010932) | 2.39690651 |
91 | Mitral valve prolapse (HP:0001634) | 2.39579311 |
92 | Nuclear cataract (HP:0100018) | 2.37117224 |
93 | Malnutrition (HP:0004395) | 2.35310587 |
94 | Joint stiffness (HP:0001387) | 2.34004925 |
95 | Mitral regurgitation (HP:0001653) | 2.33442198 |
96 | Ketoacidosis (HP:0001993) | 2.31648113 |
97 | Delayed CNS myelination (HP:0002188) | 2.26304645 |
98 | Aortic regurgitation (HP:0001659) | 2.25231022 |
99 | Aneurysm (HP:0002617) | 2.25160720 |
100 | Gingival bleeding (HP:0000225) | 2.22839996 |
101 | Back pain (HP:0003418) | 2.22634907 |
102 | Hyperextensible skin (HP:0000974) | 2.22354012 |
103 | Biconcave vertebral bodies (HP:0004586) | 2.22290955 |
104 | Spastic diplegia (HP:0001264) | 2.21079486 |
105 | Abnormal delivery (HP:0001787) | 2.20137663 |
106 | Neurofibrillary tangles (HP:0002185) | 2.19778517 |
107 | Pancreatitis (HP:0001733) | 2.19725698 |
108 | Abnormality of purine metabolism (HP:0004352) | 2.19675173 |
109 | Menorrhagia (HP:0000132) | 2.19670951 |
110 | Metabolic acidosis (HP:0001942) | 2.19218988 |
111 | Osteolytic defects of the hand bones (HP:0009699) | 2.18011180 |
112 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.18011180 |
113 | Increased variability in muscle fiber diameter (HP:0003557) | 2.15972612 |
114 | Elbow flexion contracture (HP:0002987) | 2.14353509 |
115 | Increased connective tissue (HP:0009025) | 2.13222385 |
116 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.12294450 |
117 | Ovoid vertebral bodies (HP:0003300) | 2.12093883 |
118 | Acanthocytosis (HP:0001927) | 2.11033719 |
119 | Vacuolated lymphocytes (HP:0001922) | 2.10673639 |
120 | Peritonitis (HP:0002586) | 2.10567857 |
121 | Nephritis (HP:0000123) | 2.09244327 |
122 | Abnormality of the acetabulum (HP:0003170) | 2.09081076 |
123 | Ulnar bowing (HP:0003031) | 2.06728535 |
124 | Hemorrhage of the eye (HP:0011885) | 2.06598337 |
125 | Thin bony cortex (HP:0002753) | 2.05734357 |
126 | Abnormal cartilage morphology (HP:0002763) | 2.04553214 |
127 | Increased mean platelet volume (HP:0011877) | 2.04433972 |
128 | Short nail (HP:0001799) | 2.04029505 |
129 | Persistence of primary teeth (HP:0006335) | 2.02097174 |
130 | Abnormality of serum amino acid levels (HP:0003112) | 1.99455159 |
131 | Abnormal gallbladder morphology (HP:0012437) | 1.99063744 |
132 | Mildly elevated creatine phosphokinase (HP:0008180) | 1.98306505 |
133 | Neonatal onset (HP:0003623) | 1.97885824 |
134 | Slender build (HP:0001533) | 1.97855847 |
135 | Hypochromic microcytic anemia (HP:0004840) | 1.97520877 |
136 | Stroke (HP:0001297) | 1.97151363 |
137 | Spontaneous hematomas (HP:0007420) | 1.96131209 |
138 | Joint laxity (HP:0001388) | 1.95503007 |
139 | Cholelithiasis (HP:0001081) | 1.95093964 |
140 | Distal lower limb muscle weakness (HP:0009053) | 1.94718138 |
141 | Natal tooth (HP:0000695) | 1.92879052 |
142 | Aortic valve stenosis (HP:0001650) | 1.91462347 |
143 | Right ventricular cardiomyopathy (HP:0011663) | 1.91356767 |
144 | Alopecia of scalp (HP:0002293) | 1.90863477 |
145 | Cholecystitis (HP:0001082) | 1.90467072 |
146 | Abnormal gallbladder physiology (HP:0012438) | 1.90467072 |
147 | Asymmetric septal hypertrophy (HP:0001670) | 1.89565267 |
148 | Abnormality of the Achilles tendon (HP:0005109) | 1.87561343 |
149 | Cerebral inclusion bodies (HP:0100314) | 1.87452473 |
150 | Nonimmune hydrops fetalis (HP:0001790) | 1.87381857 |
151 | Sensorimotor neuropathy (HP:0007141) | 1.86973435 |
152 | Wrist flexion contracture (HP:0001239) | 1.86760720 |
153 | Hypoglycemic seizures (HP:0002173) | 1.85816719 |
154 | Dicarboxylic aciduria (HP:0003215) | 1.84762030 |
155 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.84762030 |
156 | Wide anterior fontanel (HP:0000260) | 1.84131602 |
157 | Upper limb amyotrophy (HP:0009129) | 1.83751365 |
158 | Distal upper limb amyotrophy (HP:0007149) | 1.83751365 |
159 | Protrusio acetabuli (HP:0003179) | 1.83310949 |
160 | Abnormal platelet volume (HP:0011876) | 1.82976887 |
161 | Coxa vara (HP:0002812) | 1.81926190 |
162 | Abnormality of carpal bone ossification (HP:0006257) | 1.81654266 |
163 | Keratoconjunctivitis sicca (HP:0001097) | 1.79405952 |
164 | Orchitis (HP:0100796) | 1.79265029 |
165 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.77054776 |
166 | Purpura (HP:0000979) | 1.76081993 |
167 | Generalized amyotrophy (HP:0003700) | 1.75568993 |
168 | Hypoplasia of the iris (HP:0007676) | 1.73944840 |
169 | Abnormality of iron homeostasis (HP:0011031) | 1.73940937 |
170 | Femoral bowing (HP:0002980) | 1.73761049 |
171 | Rickets (HP:0002748) | 1.72992358 |
172 | Bowel diverticulosis (HP:0005222) | 1.72892126 |
173 | Overgrowth (HP:0001548) | 1.72775724 |
174 | Ectopia lentis (HP:0001083) | 1.71920451 |
175 | Venous abnormality (HP:0002624) | 1.71666620 |
176 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.70062590 |
177 | Gout (HP:0001997) | 1.69832331 |
178 | Joint swelling (HP:0001386) | 1.68769230 |
179 | Enlarged kidneys (HP:0000105) | 1.66862577 |
180 | Interstitial pulmonary disease (HP:0006530) | 1.66645680 |
Rank | Gene Set | Z-score |
---|---|---|
1 | TAOK3 | 3.96406773 |
2 | SIK1 | 3.75470304 |
3 | ERN1 | 3.70265194 |
4 | FGFR4 | 3.50030944 |
5 | BCKDK | 2.82225991 |
6 | TRIB3 | 2.70672335 |
7 | MAPK15 | 2.69793258 |
8 | IRAK3 | 2.68330497 |
9 | LATS2 | 2.32364400 |
10 | TESK1 | 2.26393792 |
11 | TGFBR2 | 2.20100809 |
12 | JAK1 | 2.04080006 |
13 | PKN2 | 2.02932167 |
14 | PIM2 | 2.01990363 |
15 | EPHB1 | 1.96477895 |
16 | MAP3K14 | 1.93692837 |
17 | TBK1 | 1.88661696 |
18 | MOS | 1.83414620 |
19 | TIE1 | 1.82340347 |
20 | PTK6 | 1.80230490 |
21 | LATS1 | 1.72416934 |
22 | MAP4K1 | 1.65961519 |
23 | LIMK1 | 1.64105422 |
24 | ERBB4 | 1.62320178 |
25 | NTRK1 | 1.61441159 |
26 | TAOK2 | 1.57636521 |
27 | EPHA3 | 1.57391836 |
28 | CDC42BPA | 1.57351006 |
29 | NME2 | 1.54892306 |
30 | MAP3K3 | 1.54583961 |
31 | TYK2 | 1.51440647 |
32 | ICK | 1.50588024 |
33 | GRK6 | 1.50532233 |
34 | KDR | 1.48705204 |
35 | MST1R | 1.41412037 |
36 | ARAF | 1.29515593 |
37 | GRK7 | 1.26449369 |
38 | PTK2 | 1.20449130 |
39 | GSK3A | 1.18172008 |
40 | RIPK1 | 1.17980527 |
41 | LRRK2 | 1.16718190 |
42 | PRPF4B | 1.13309959 |
43 | BMX | 1.12265247 |
44 | FGFR3 | 1.10847171 |
45 | CSK | 1.10280408 |
46 | NEK9 | 1.08473194 |
47 | MAP2K3 | 1.08124243 |
48 | EPHA2 | 1.07980233 |
49 | STK24 | 1.07777668 |
50 | CHUK | 1.06999057 |
51 | PRKD2 | 1.06229165 |
52 | DMPK | 1.06149739 |
53 | EPHB2 | 1.01678568 |
54 | STK38 | 0.99782232 |
55 | INSRR | 0.99546703 |
56 | FRK | 0.97677261 |
57 | GRK1 | 0.97070453 |
58 | PIK3CG | 0.97030486 |
59 | IKBKB | 0.96897803 |
60 | TXK | 0.96791066 |
61 | PRKAA2 | 0.95849703 |
62 | ITK | 0.94958670 |
63 | DAPK3 | 0.94083748 |
64 | ILK | 0.91301091 |
65 | IKBKE | 0.89411155 |
66 | MAPKAPK3 | 0.89385369 |
67 | PDGFRA | 0.89258701 |
68 | MAP3K6 | 0.88636179 |
69 | MAP3K7 | 0.83841264 |
70 | TRPM7 | 0.83621379 |
71 | CDK6 | 0.83116557 |
72 | MAPK11 | 0.80849792 |
73 | JAK2 | 0.80518797 |
74 | FER | 0.79578630 |
75 | STK10 | 0.79113814 |
76 | ROCK2 | 0.76614537 |
77 | TTN | 0.76545701 |
78 | ROCK1 | 0.76378674 |
79 | MAP3K1 | 0.73236538 |
80 | MAP3K12 | 0.72712390 |
81 | LMTK2 | 0.72243079 |
82 | BTK | 0.72046230 |
83 | RPS6KA2 | 0.71629926 |
84 | TEC | 0.71582571 |
85 | MAP3K10 | 0.69977614 |
86 | FLT3 | 0.69932246 |
87 | ZAP70 | 0.69710350 |
88 | ABL2 | 0.69429998 |
89 | PDGFRB | 0.69201221 |
90 | JAK3 | 0.66982983 |
91 | DDR2 | 0.66739588 |
92 | MTOR | 0.65923653 |
93 | RPS6KA4 | 0.63957381 |
94 | FGFR2 | 0.63254013 |
95 | CSF1R | 0.63027392 |
96 | ERBB2 | 0.61661020 |
97 | TYRO3 | 0.61037080 |
98 | PRKCQ | 0.60380185 |
99 | IGF1R | 0.57897035 |
100 | PAK2 | 0.56739919 |
101 | RET | 0.55277284 |
102 | TAOK1 | 0.55248939 |
103 | DYRK1B | 0.55055660 |
104 | EEF2K | 0.54912631 |
105 | MAP2K4 | 0.54579505 |
106 | PIM1 | 0.54538662 |
107 | PRKCZ | 0.54328814 |
108 | MYLK | 0.54272852 |
109 | MAPK4 | 0.53861530 |
110 | STK38L | 0.53455056 |
111 | MAPK7 | 0.52825635 |
112 | PDPK1 | 0.52806778 |
113 | STK3 | 0.52454173 |
114 | MAP3K11 | 0.51708412 |
115 | MET | 0.51135101 |
116 | AKT3 | 0.50830824 |
117 | PRKD1 | 0.50018009 |
118 | PRKG2 | 0.49873292 |
119 | PDK2 | 0.48392411 |
120 | MAP2K2 | 0.48377051 |
121 | MAPK12 | 0.46797479 |
122 | PTK2B | 0.45331466 |
123 | KSR2 | 0.45254237 |
124 | CAMK2G | 0.44740115 |
125 | SMG1 | 0.44402324 |
126 | INSR | 0.44364242 |
127 | MAP2K1 | 0.44256380 |
128 | HCK | 0.44134677 |
129 | ABL1 | 0.42702723 |
130 | MAP3K2 | 0.41244993 |
131 | KIT | 0.40334013 |
132 | NLK | 0.40206713 |
133 | TGFBR1 | 0.39189874 |
134 | PRKCH | 0.38546071 |
135 | PAK4 | 0.37510864 |
136 | MAP3K13 | 0.37318892 |
137 | CAMK1D | 0.37093851 |
138 | PRKD3 | 0.35813338 |
139 | PAK6 | 0.35783851 |
140 | MAP3K5 | 0.35360879 |
141 | RPS6KC1 | 0.33595597 |
142 | RPS6KL1 | 0.33595597 |
143 | SRC | 0.32094898 |
144 | MAPKAPK2 | 0.31881895 |
145 | MATK | 0.31424015 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 4.37714262 |
2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.54102951 |
3 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 3.39437577 |
4 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.22627061 |
5 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.97933916 |
6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.90984510 |
7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.83866256 |
8 | Other glycan degradation_Homo sapiens_hsa00511 | 2.83619316 |
9 | Tryptophan metabolism_Homo sapiens_hsa00380 | 2.71529076 |
10 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 2.56359646 |
11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.55388048 |
12 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 2.23563992 |
13 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 2.17160359 |
14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.14293057 |
15 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 2.13293224 |
16 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 2.12614083 |
17 | PPAR signaling pathway_Homo sapiens_hsa03320 | 2.11786841 |
18 | Lysosome_Homo sapiens_hsa04142 | 1.96514790 |
19 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.94380698 |
20 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.92522129 |
21 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.91192618 |
22 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.88456384 |
23 | Peroxisome_Homo sapiens_hsa04146 | 1.87681159 |
24 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.86627768 |
25 | Retinol metabolism_Homo sapiens_hsa00830 | 1.85639386 |
26 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.78712669 |
27 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.76870239 |
28 | Histidine metabolism_Homo sapiens_hsa00340 | 1.73477207 |
29 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.60797779 |
30 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.54522389 |
31 | Bile secretion_Homo sapiens_hsa04976 | 1.49600061 |
32 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.48480216 |
33 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.48387714 |
34 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.46890189 |
35 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.45437058 |
36 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.45321228 |
37 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.41220728 |
38 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.29329494 |
39 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 1.29259903 |
40 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.28820338 |
41 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.28407054 |
42 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.27180929 |
43 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.22702246 |
44 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.17345743 |
45 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.17114747 |
46 | Salmonella infection_Homo sapiens_hsa05132 | 1.16534998 |
47 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.14486536 |
48 | ABC transporters_Homo sapiens_hsa02010 | 1.09697518 |
49 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.06194695 |
50 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.02301702 |
51 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.01783832 |
52 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.01345934 |
53 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.97377585 |
54 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.95803890 |
55 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.95341992 |
56 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.92785223 |
57 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.91567291 |
58 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.90919375 |
59 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.88917050 |
60 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.87593696 |
61 | Folate biosynthesis_Homo sapiens_hsa00790 | 0.85994540 |
62 | Carbon metabolism_Homo sapiens_hsa01200 | 0.85475534 |
63 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.84275955 |
64 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.83252727 |
65 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.82081228 |
66 | Phagosome_Homo sapiens_hsa04145 | 0.81878178 |
67 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.81774020 |
68 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.81737835 |
69 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.77602697 |
70 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.77279307 |
71 | Adherens junction_Homo sapiens_hsa04520 | 0.76506565 |
72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.75850173 |
73 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.75660937 |
74 | Lysine degradation_Homo sapiens_hsa00310 | 0.75383163 |
75 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.75019222 |
76 | Sulfur relay system_Homo sapiens_hsa04122 | 0.74843146 |
77 | Mineral absorption_Homo sapiens_hsa04978 | 0.73695593 |
78 | Shigellosis_Homo sapiens_hsa05131 | 0.73360090 |
79 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.73134603 |
80 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.73053741 |
81 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.72914507 |
82 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.72575805 |
83 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.71848574 |
84 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.71625359 |
85 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.71199078 |
86 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.66641284 |
87 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.64649956 |
88 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.63726163 |
89 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.62486325 |
90 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.61263744 |
91 | Hepatitis C_Homo sapiens_hsa05160 | 0.56137506 |
92 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.56076991 |
93 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.55294903 |
94 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.54847685 |
95 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 0.53233925 |
96 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.52008027 |
97 | Insulin resistance_Homo sapiens_hsa04931 | 0.50776882 |
98 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.50701896 |
99 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.49487975 |
100 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.47821272 |
101 | Prion diseases_Homo sapiens_hsa05020 | 0.46931186 |
102 | Endocytosis_Homo sapiens_hsa04144 | 0.46889434 |
103 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.45564973 |
104 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.44014289 |
105 | Pathways in cancer_Homo sapiens_hsa05200 | 0.43456210 |
106 | Tuberculosis_Homo sapiens_hsa05152 | 0.43244555 |
107 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.43106270 |
108 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.42581754 |
109 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.40725796 |
110 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.39015890 |
111 | Leishmaniasis_Homo sapiens_hsa05140 | 0.38908696 |
112 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.38522516 |
113 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.38188293 |
114 | Melanoma_Homo sapiens_hsa05218 | 0.37892384 |
115 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.37703421 |
116 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.37624313 |
117 | Apoptosis_Homo sapiens_hsa04210 | 0.35825941 |
118 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.34825660 |
119 | Tight junction_Homo sapiens_hsa04530 | 0.34474694 |
120 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.31793264 |
121 | Circadian rhythm_Homo sapiens_hsa04710 | 0.26630678 |
122 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.25445358 |
123 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.21826216 |
124 | Metabolic pathways_Homo sapiens_hsa01100 | 0.20898502 |
125 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.19129121 |
126 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.18729691 |
127 | Amoebiasis_Homo sapiens_hsa05146 | 0.18697222 |
128 | Galactose metabolism_Homo sapiens_hsa00052 | 0.18131626 |
129 | Focal adhesion_Homo sapiens_hsa04510 | 0.13497430 |
130 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.10549567 |
131 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.10296205 |
132 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.08571586 |
133 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.08242228 |
134 | Malaria_Homo sapiens_hsa05144 | 0.08020509 |
135 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.07801917 |
136 | Bladder cancer_Homo sapiens_hsa05219 | 0.07686038 |
137 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.07293691 |
138 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.06499068 |
139 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.05976295 |
140 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.05042533 |
141 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.04536905 |
142 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.03744245 |
143 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.02434931 |
144 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.01282392 |
145 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.00609217 |
146 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.00229010 |
147 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | -0.0031145 |
148 | Pertussis_Homo sapiens_hsa05133 | -0.0021323 |